Vizgen, Inc is a pioneering genomics company based in Cambridge, MA, dedicated to advancing the field of spatial genomics. Their MERSCOPE Platform combines single-cell and spatial genomics, providing researchers with high multiplexing and high-resolution in situ capabilities. Powered by their proprietary MERFISH technology, this platform enables the identification of nucleic acids in their native tissue environment with exceptional resolution, ranging from subcellular to tissue scale.
Vizgen's tools are revolutionizing the study of biological systems and offering new insights into human health and disease by incorporating spatial context. Their MERSCOPE Immuno-Oncology Panel allows researchers to characterize tumor and immune behavior at cellular and subcellular levels across various types of human cancers. Additionally, their user-friendly Gene Panel Design Portal facilitates the creation of custom MERFISH gene panels for use on the MERSCOPE Platform. With a commitment to innovation and comprehensive cellular mapping, Vizgen is at the forefront of visualizing gene expression in situ.
Generated from the website